Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled date : 2022 - 04 - 27 save search
Mirati Therapeutics to Present New Research at the 2022 ASCO Annual Meeting Showcasing Clinical Advances of Treating KRASG12C-Mutated Lung Cancer with Investigational Adagrasib
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.21%
H: 0.88%
C: -2.15%
krasg12 research therapeutics asco cancer
Aligos Therapeutics to Announce First Quarter 2022 Results May 4, 2022
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
ALGS | $0.7931 25K
|
Health Technology
|
| O: -0.77%
H: 6.24%
C: -1.57%
therapeutics results
MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update
Published: 2022-04-27 (Crawled : 22:00) - globenewswire.com
INKT | $0.8717 3.6K
|
|
| O: -2.89%
H: 0.0%
C: -10.24%
report therapeutics results
Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-04-27 (Crawled : 21:00) - biospace.com/
VKTX | $64.21 -0.71% 840K
|
Health Technology
|
| O: 0.44%
H: 0.87%
C: -4.35%
LGND | $71.255 -1.74% 19K
|
Health Technology
|
| O: -0.08%
H: 1.83%
C: -1.41%
therapeutics results
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone
Published: 2022-04-27 (Crawled : 21:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
|
| O: -6.25%
H: 0.0%
C: -6.67%
biopharma therapeutics
Clarus Therapeutics Announces Closing of Upsized $30.0 Million Underwritten Public Offering
Published: 2022-04-27 (Crawled : 18:00) - globenewswire.com
CRXT | $0.0475
|
|
| O: -3.98%
H: 3.55%
C: -3.79%
offering therapeutics
LAVA Therapeutics to Present Updated LAVA-051 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-04-27 (Crawled : 14:20) - globenewswire.com
LVTX | $2.73 -3.53% 99K
|
|
| O: -1.23%
H: 1.49%
C: -0.75%
lava-051 therapeutics
Onconova Therapeutics Announces Acceptance of Abstract for Publication at the ASCO Annual Meeting
Published: 2022-04-27 (Crawled : 14:20) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: 1.44%
H: 2.84%
C: -1.42%
therapeutics asco publication
Allogene Therapeutics to Report First Quarter 2022 Financial Results on May 4, 2022
Published: 2022-04-27 (Crawled : 14:00) - biospace.com/
ALLO | $3.505 1.3% 290K
|
Health Technology
|
| O: -0.24%
H: 3.32%
C: -0.59%
report therapeutics results
Allogene Therapeutics Receives FDA Orphan-Drug Designation for ALLO-605, its First TurboCAR™ T Cell Product Candidate, for the Treatment of Multiple Myeloma
Published: 2022-04-27 (Crawled : 14:00) - biospace.com/
ALLO | $3.505 1.3% 290K
|
Health Technology
|
| O: -0.24%
H: 3.32%
C: -0.59%
allo-605 treatment fda designation therapeutics
Atossa Therapeutics to Present at the Q2 Investor Summit Conference
Published: 2022-04-27 (Crawled : 14:00) - globenewswire.com
ATOS | $1.375 -3.17% 430K
|
Health Technology
|
| O: 3.63%
H: 12.0%
C: 11.0%
conference therapeutics
Highland Therapeutics Announces Appointment of Stephanie C. Read as President/CEO, Changes to Board of Directors
Published: 2022-04-27 (Crawled : 13:00) - biospace.com/
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
DHR | $235.02 -0.57% 750K
|
Health Technology
|
| O: -2.05%
H: 1.77%
C: -0.42%
therapeutics
Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022
Published: 2022-04-27 (Crawled : 13:00) - biospace.com/
SRPT | $115.845 -0.61% 120K
|
Health Technology
|
| O: -4.8%
H: 2.57%
C: 2.32%
therapeutics results
Worldwide KRAS Inhibitors Market to 2028 - Featuring Amgen, Mirati Therapeutics and Eli Lilly Among Others
Published: 2022-04-27 (Crawled : 13:00) - prnewswire.com
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
therapeutics market
Horizon Therapeutics plc Among Top Companies for Overall Corporate Reputation in 2021 Global PatientView Survey of Patient Groups Worldwide
Published: 2022-04-27 (Crawled : 12:20) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -3.01%
H: 0.64%
C: -1.31%
companies therapeutics
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report First-Quarter 2022 Financial Results and Discuss Recent Corporate Highlights
Published: 2022-04-27 (Crawled : 12:20) - biospace.com/
ALDX | News | $3.85 -3.27% 130K
|
Health Technology
|
| O: -0.58%
H: 2.2%
C: -1.17%
conference report therapeutics results
Entasis Therapeutics Announces First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-04-27 (Crawled : 12:20) - biospace.com/
ETTX | $2.19 -0.46% 0.46%
|
Health Technology
|
| O: -0.53%
H: 2.66%
C: -0.53%
therapeutics results
Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022
Published: 2022-04-27 (Crawled : 12:20) - biospace.com/
TAK | News | $13.255 0.72% 200K
|
Health Technology
|
| O: -0.76%
H: 0.66%
C: 0.28%
JNJ | News | $146.39 0.45% 1.8M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
ARCT 4 | $26.305 -0.06% 65K
|
Health Technology
|
| O: -6.84%
H: 1.52%
C: -3.65%
report therapeutics results
Cellectis Receives $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics
Published: 2022-04-27 (Crawled : 07:00) - globenewswire.com
ISLE | $10.01 0.1%
|
|
| O: 0.0%
H: 0.1%
C: 0.0%
CLLS | $2.47 10K
|
Health Technology
|
| O: -0.83%
H: 15.88%
C: 6.69%
collaboration therapeutics
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom
Published: 2022-04-27 (Crawled : 03:00) - alteritytherapeutics.com
ATHE | $2.06 -3.74% 35K
|
Health Technology
|
| O: 0.7%
H: 2.6%
C: -2.0%
ath434 trial therapeutics authorization phase 2
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.